Cynthia Chen

Chairwoman, Pulnovo Medical

 

For spearheading treatment of pulmonary arterial hypertension

Credit Suisse

Medical device company Pulnovo Medical is pioneering treatment for cardiopulmonary diseases. Chaired by Cynthia Chen, the company’s core product is its PADN (Pulmonary Artery Denervation) device, which uses radiofrequency ablation to treat pulmonary arterial hypertension. In 2021, the product was granted the Breakthrough Device designation by the US Food and Drug Administration.

ADVERTISEMENT - CONTENT CONTINUES BELOW

Recognitions


© 2022 Tatler Asia Limited. All rights reserved.
This website uses cookies to improve your experience. See our privacy policy.